Pharmaceutical Investing Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor